Autologous stem-cell transplantation for solid tumors in adultsNIETO, Y; SHPALL, E. J.Hematology/oncology clinics of North America. 1999, Vol 13, Num 5, issn 0889-8588, vi,939-968 [31 p.]Article

The role and methodology for purging tumor from autologous bone marrow and peripheral blood progenitor cellsPURDY, M. H; SHPALL, E. J.Medical oncology and tumor pharmacotherapy. 1994, Vol 11, Num 2, pp 47-51, issn 0736-0118Conference Paper

Mobilization and selection of CD34-positive hematopoietic progenitorsCAGNOGNI, P. J; SHPALL, E. J.Blood reviews. 1996, Vol 10, Num 1, pp 1-7, issn 0268-960XArticle

Treatment of breast cancer in the 1990s : what does the future hold ?JONES, R. B; SHPALL, E. J.Drugs (Basel). 1992, Vol 43, Num 2, pp 141-145, issn 0012-6667Article

Bone metastases from breast cancer : value of CT bone windowsVANDEMARK, R. M; SHPALL, E. J; AFFRONTI, M. L et al.Journal of computer assisted tomography. 1992, Vol 16, Num 4, pp 608-614, issn 0363-8715Article

Intravenous BU plus Mel: an effective, chemotherapy-only transplant conditioning regimen in patients with ALLKEBRIAEI, P; MADDEN, T; ALOUSI, A et al.Bone marrow transplantation (Basingstoke). 2013, Vol 48, Num 1, pp 26-31, issn 0268-3369, 6 p.Article

Prognostic analysis of tumour angiogenesis, determined by microvessel density and expression of vascular endothelial growth factor, in high-risk primary breast cancer patients treated with high-dose chemotherapyNIETO, Y; WOODS, J; NAWAZ, F et al.British journal of cancer. 2007, Vol 97, Num 3, pp 391-397, issn 0007-0920, 7 p.Article

Phase II trial of high-dose chemotherapy with autologous stem cell transplant for stage IV breast cancer with minimal metastatic diseaseNIETO, Y; CAGNONI, P. J; SHPALL, E. J et al.Clinical cancer research. 1999, Vol 5, Num 7, pp 1731-1737, issn 1078-0432Article

Optic disc and retinal microvasculopathy after high-dose chemotherapy and autologous hematopoietic progenitor cell supportJOHNSON, D. W; CAGNONI, P. J; SCHOSSAU, T. M et al.Bone marrow transplantation (Basingstoke). 1999, Vol 24, Num 7, pp 785-792, issn 0268-3369Article

Peripheral blood stem cells for autograftingSHPALL, E. J; CAGNONI, P. J; BEARMAN, S. I et al.Annual review of medicine. 1997, Vol 48, pp 241-251, issn 0066-4219Article

High-dose chemotherapy with autologous peripheral blood progenitor cell support for primary breast cancer in patients with 4-9 involved axillary lymph nodesBEARMAN, S. I; OVERMOYER, B. A; ROSS, M et al.Bone marrow transplantation (Basingstoke). 1997, Vol 20, Num 11, pp 931-937, issn 0268-3369Article

Rapid and efficient selection of human hematopoietic cells expressing murine heat-stable antigen as an indicator of retroviral-mediated gene transferCONNEALLY, E; BARDY, P; EAVES, C. J et al.Blood. 1996, Vol 87, Num 2, pp 456-464, issn 0006-4971Article

Use of amifostine in bone marrow purgingCAGNONI, P. J; JONES, R. B; BEARMAN, S. I et al.Seminars in oncology. 1996, Vol 23, Num 4, pp 44-48, issn 0093-7754, SUP8Conference Paper

Failure is not fatal: long-term remission in refractory acute myeloid leukemia (AML) after graft failure of cord blood stem cellsBURGER, J. A; VELEV, N. S; JABBOUR, E. J et al.Leukemia. 2010, Vol 24, Num 3, pp 666-668, issn 0887-6924, 3 p.Article

Identifying candidate allogeneic NK-cell donors for hematopoietic stem-cell transplantation based on functional phenotypeHURTON, L. V; SIDDIK, R. I; CHAMPLIN, R et al.Leukemia. 2010, Vol 24, Num 5, pp 1059-1062, issn 0887-6924, 4 p.Article

Microbial contamination of hematopoietic progenitor cell products : clinical outcomePATAH, P. A; PARMAR, S; MCMANNIS, J et al.Bone marrow transplantation (Basingstoke). 2007, Vol 40, Num 4, pp 365-368, issn 0268-3369, 4 p.Article

Acute pancreatitis during immunosuppression with tacrolimus following an allogeneic umbilical cord blood transplantationNIETO, Y; RUSS, P; EVERSON, G et al.Bone marrow transplantation (Basingstoke). 2000, Vol 26, Num 1, pp 109-111, issn 0268-3369Article

Acute encephalopathy : A new toxicity associated with high-dose paclitaxel¹NIETO, Y; CAGNONI, P. J; BEARMAN, S. I et al.Clinical cancer research. 1999, Vol 5, Num 3, pp 501-506, issn 1078-0432Article

Incidence of tumor-cell contamination in leukapheresis products of breast cancer patients mobilized with stem cell factor and granulocyte colony-stimulating factor (G-CSF) or with G-CSF aloneFRANKLIN, W. A; GLASPY, J; PFLAUMER, S. M et al.Blood. 1999, Vol 94, Num 1, pp 340-347, issn 0006-4971Article

Immunocytochemical detection of breast cancer cells in marrow and peripheral blood of patients undergoing high dose chemotherapy with autologous stem cell supportFRANKLIN, W. A; SHPALL, E. J; ARCHER, P et al.Breast cancer research and treatment. 1996, Vol 41, Num 1, pp 1-13, issn 0167-6806Article

Bone marrow involvement by lobular carcinoma of the breast cannot be identified reliably by routine histological examination aloneBITTER, M. A; FIORITO, D; CORKILL, M. E et al.Human pathology. 1994, Vol 25, Num 8, pp 781-788, issn 0046-8177Article

Acute lung injury following treatment with high-dose cyclophosphamide, cisplatin, and carmustine : pharmacodynamic evaluation of carmustineJONES, R. B; MATTHES, S; SHPALL, E. J et al.Journal of the National Cancer Institute. 1993, Vol 85, Num 8, pp 640-647, issn 0027-8874Article

FOXP3 is a direct target of miR15a/16 in umbilical cord blood regulatory T cellsLIU, X; ROBINSON, S. N; KONOPLEVA, M et al.Bone marrow transplantation (Basingstoke). 2014, Vol 49, Num 6, pp 793-799, issn 0268-3369, 7 p.Article

Transplantation of ex vivo expanded cord blood cells using the copper chelator tetraethylenepentamine : a phase I/II clinical trialDE LIMA, M; MCMANNIS, J; KARANDISH, S et al.Bone marrow transplantation (Basingstoke). 2008, Vol 41, Num 9, pp 771-778, issn 0268-3369, 8 p.Article

Risk factors associated with late cytomegalovirus reactivation after allogeneic stem cell transplantation for hematological malignanciesÖZDEMIR, E; SALIBA, R. M; SHPALL, E. J et al.Bone marrow transplantation (Basingstoke). 2007, Vol 40, Num 2, pp 125-136, issn 0268-3369, 12 p.Article